AGAPE ATP CORPORATION Increase (Decrease) in Accounts Receivable, Related Parties
AGAPE ATP CORPORATION (ATPC) reported Increase (Decrease) in Accounts Receivable, Related Parties of $8.62 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2021-08-13
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable, related parties for the quarter ending 2020-06-30 was $8.90K, a 96.39% decline year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable, related parties for the quarter ending 2020-03-31 was -$285.00, a 100.15% decline year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable, related parties for the quarter ending 2019-12-31 was -$31.37K.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable, related parties for the quarter ending 2019-09-30 was $116.97K.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable, related parties for fiscal 2019 was $518.94K.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable, related parties for fiscal 2019 was $433.34K.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 9 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month |
|---|---|---|---|---|
| 2020-06-30 | $8.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $8.62K 10-Q · filed 2021-08-13 | -$22.75K derived: sum of 3 quarters · filed 2021-08-13 | $94.22K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | -$285.00 10-Q · filed 2021-05-17 | -$31.66K derived: sum of 2 quarters · filed 2021-05-17 | $85.32K derived: sum of 3 quarters · filed 2021-05-17 | $332.12K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$31.37K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $85.60K 10-K · filed 2021-03-31 | $332.40K derived: sum of 3 quarters · filed 2021-03-31 | $518.94K 10-K · filed 2021-03-31 |
| 2019-09-30 | $116.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $363.77K derived: sum of 2 quarters · filed 2020-11-16 | $550.31K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $246.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $433.34K 10-Q · filed 2020-08-13 | $433.34K 10-K · filed 2020-03-27 | |
| 2019-03-31 | $186.54K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |